Efficacy and safety of tenapanor in patients with constipation predominant irritable bowel syndrome: A 12-week, double-blind, placebo-controlled, randomized phase 2B trial

Category Primary study
JournalGastroenterology
Year 2015
This article has no abstract
Epistemonikos ID: dc3201ae559e0af0001afe08fcb7b5da27525b41
First added on: Feb 07, 2025